Sartorius Stedim Biotech SA (DIM) - Total Liabilities

Latest as of September 2025: €3.81 Billion EUR

Based on the latest financial reports, Sartorius Stedim Biotech SA (DIM) has total liabilities worth €3.81 Billion EUR as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Sartorius Stedim Biotech SA - Total Liabilities Trend (2005–2024)

This chart illustrates how Sartorius Stedim Biotech SA's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Sartorius Stedim Biotech SA Competitors by Total Liabilities

The table below lists competitors of Sartorius Stedim Biotech SA ranked by their total liabilities.

Company	Country	Total Liabilities
Rongsheng Petrochemical Co Ltd SHE:002493	China	CN¥296.47 Billion
ZSCALER INC. DL-,001 XETRA:0ZC	Germany	€4.56 Billion
NIO Inc. BA:NIO	Argentina	AR$99.96 Billion
Reliance Steel & Aluminum Co NYSE:RS	USA	$3.19 Billion
China Shipbuilding Industry Co Ltd SHG:601989	China	CN¥135.25 Billion
DESTEK FINANS FAKTORING IS:DSTKF	Turkey	TL36.29 Billion
China Overseas Land & Investment Limited F:CPP	Germany	€483.81 Billion
Lennox International Inc NYSE:LII	USA	$2.92 Billion

Liability Composition Analysis (2005–2024)

This chart breaks down Sartorius Stedim Biotech SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.05	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.94	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.48	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sartorius Stedim Biotech SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sartorius Stedim Biotech SA (2005–2024)

The table below shows the annual total liabilities of Sartorius Stedim Biotech SA from 2005 to 2024.

Year	Total Liabilities	Change
2024-12-31	€4.23 Billion	-16.46%
2023-12-31	€5.07 Billion	+98.60%
2022-12-31	€2.55 Billion	+15.03%
2021-12-31	€2.22 Billion	+39.80%
2020-12-31	€1.59 Billion	+146.80%
2019-12-31	€642.79 Million	+22.07%
2018-12-31	€526.59 Million	+0.41%
2017-12-31	€524.45 Million	+21.32%
2016-12-31	€432.29 Million	+3.19%
2015-12-31	€418.92 Million	+13.76%
2014-12-31	€368.25 Million	-5.43%
2013-12-31	€389.39 Million	+8.42%
2012-12-31	€359.14 Million	+10.49%
2011-12-31	€325.04 Million	+11.59%
2010-12-31	€291.27 Million	+6.05%
2009-12-31	€274.66 Million	-2.15%
2008-12-31	€280.70 Million	+0.98%
2007-12-31	€277.96 Million	+33.37%
2006-12-31	€208.41 Million	-2.69%
2005-12-31	€214.18 Million	--

About Sartorius Stedim Biotech SA

PA:DIM France Medical Instruments & Supplies

Market Cap

$21.46 Billion

€18.36 Billion EUR

Market Cap Rank

#1319 Global

#28 in France

Share Price

€188.70

Change (1 day)

+3.57%

52-Week Range

€160.15 - €223.00

All Time High

€542.33